David J. Brooks

Peter J. Hunter, Bruce H. Smaill, David J. Brooks, 2011, 2011 Annual International Conference of the IEEE Engineering in Medicine and Biology Society.

Three-dimensional probabilistic atlas of the human brain

Alexander Hammers, David J. Brooks, John S. Duncan, 2002 .

SS-12-3 PET studies on basal ganglia function

David J. Brooks, 1995 .

Investigating the reproducibility of the novel Alpha-5 GABAA receptor PET ligand [11C]Ro15 4513

Alexander Hammers, Federico E. Turkheimer, David J. Brooks, 2010, NeuroImage.

A H2 15O Positron Emission Tomography Study on Mental Imagery of Movement Sequences—The Effect of Modulating Sequence Length and Direction

Markus Schwaiger, David J. Brooks, Alain Dagher, 2002, NeuroImage.

The effects of zolpidem on in vivo binding of [C11]-flumazenil and [C11]-Ro15-4513

Federico E. Turkheimer, David J. Brooks, David J. Nutt, 2010, NeuroImage.

Volumes, spatial extents and a probabilistic atlas of the human basal ganglia and thalamus

Alexander Hammers, Federico E. Turkheimer, David J. Brooks, 2007, NeuroImage.

Does inflammation precede tau aggregation in early Alzheimer's disease? A PET study

David J. Brooks, Michael Sommerauer, Per Borghammer, 2018, Neurobiology of Disease.

Impaired mesial frontal and putamen activation in Parkinson's disease :a PET study

David J. Brooks, R. S. J. Frackowiak, E. Diane Playford, 1992 .

Positron emission tomography and single-photon emission computed tomography in central nervous system drug development

David J. Brooks, D. Brooks, 2005, NeuroRX.

Imaging biomarkers in Parkinson's disease

David J. Brooks, Nicola Pavese, D. Brooks, 2011, Progress in Neurobiology.

Exogenous dopamine reduces GABA receptor availability in the human brain

David J. Brooks, Steen Jakobsen, Arne Møller, 2016, Brain and behavior.

Impaired recognition of facial expressions of anger in Parkinson's disease patients acutely withdrawn from dopamine replacement therapy

David J. Brooks, Andrew D. Lawrence, A. Lawrence, 2007, Neuropsychologia.

Evidence of dopamine dysfunction in the hypothalamus of patients with Parkinson's disease: An in vivo 11C-raclopride PET study

David J. Brooks, Marios Politis, Nicola Pavese, 2008, Experimental Neurology.

A comparison of 18F-dopa PET and inversion recovery MRI in the diagnosis of Parkinson’s disease

David J. Brooks, Kallol Ray Chaudhuri, Jo V. Hajnal, 2001, Neurology.

A Proposal for a Comprehensive Grading of Parkinson's Disease Severity Combining Motor and Non-Motor Assessments: Meeting an Unmet Need

David J. Brooks, Angelo Antonini, Pablo Martinez-Martin, 2013, PloS one.

Imaging in Parkinson’s Disease: The Role of Monoamines in Behavior

David J. Brooks, Paola Piccini, D. Brooks, 2006, Biological Psychiatry.

Neurobiological mechanism underlying decreased motivation in Parkinson’s disease: A C-11-raclopride positron emission tomography study

Kris Thielemans, David J. Brooks, Nobukatsu Sawamoto, 2006 .

Monoamine neuron innervation of the normal human brain: an 18F-DOPA PET study

David J. Brooks, Alan L. Whone, D. Brooks, 2003, Brain Research.

Imaging the GABA-Benzodiazepine Receptor Subtype Containing the α5-Subunit In Vivo with [11C]Ro15 4513 Positron Emission Tomography

Victor W. Pike, David J. Brooks, Susan P. Hume, 2002, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

Initial Evaluation of 18 F-GE-179 , A Putative PET Tracer for Activated N-Methyl D-Aspartate Receptors

Alexander Hammers, David J. Brooks, John S. Duncan, 2014 .

The genetic basis and phenotypic variability in early onset parkinsonism

David J. Brooks, Nicholas W. Wood, N. P. Quinn, 2002 .

In vivo imaging of microglial activation with [11C](R)-PK11195 PET in idiopathic Parkinson's disease

Alexander Hammers, David J. Brooks, Alexander Gerhard, 2006, Neurobiology of Disease.

A European multicentre PET study of fibrillar amyloid in Alzheimer’s disease

Paul Edison, David J. Brooks, Timo Grimmer, 2012, European Journal of Nuclear Medicine and Molecular Imaging.

In vivo assessment of brain monoamine systems in parkin gene carriers: A PET study

David J. Brooks, Andrew J. Lees, Nicholas W. Wood, 2010, Experimental Neurology.

Combination of Biomarkers: PET [18F]Flutemetamol Imaging and Structural MRI in Dementia and Mild Cognitive Impairment

Juha Koikkalainen, Jyrki Lötjönen, David J. Brooks, 2012, Neurodegenerative Diseases.

Dopaminergic action beyond its effects on motor function: Imaging studies

David J. Brooks, 2006, Journal of neurology.

Genetic impact on cognition and brain function in newly diagnosed Parkinson’s disease: ICICLE-PD study

David J. Brooks, Roger A. Barker, James B. Rowe, 2014, Brain : a journal of neurology.

Influence of microglial activation on neuronal function in Alzheimer's and Parkinson's disease dementia

Paul Edison, David J. Brooks, Brigitte Landeau, 2015, Alzheimer's & Dementia.

AMYLOID DEPOSITION, TAU AGGREGATION AND MICROGLIAL ACTIVATION CORRELATE WITH VASCULAR BURDEN IN VIVO IN ALZHEIMER'S DISEASE

Paul Edison, David J. Brooks, Melanie Wood, 2017, Alzheimer's & Dementia.

Molecular imaging of dopamine transporters

David J. Brooks, D. Brooks, 2016, Ageing Research Reviews.

Observations on muscle activity in REM sleep behavior disorder assessed with a semi-automated scoring algorithm

David J. Brooks, Jesper Jeppesen, Michael Sommerauer, 2017, Clinical Neurophysiology.

Central Benzodiazepine/γ‐Aminobutyric AcidA Receptors in Idiopathic Generalized Epilepsy: An [11C]Flumazenil Positron Emission Tomography Study

David J. Brooks, John S. Duncan, Mark P. Richardson, 1997 .

Measuring Neurotransmitter Release with PET: Methodological Issues

David J. Brooks, Alain Dagher, Roger N. Gunn, 1998 .

A Two-Compartment Description and Kinetic Procedure for Measuring Regional Cerebral [11C]Nomifensine Uptake Using Positron Emission Tomography

David J. Brooks, Eric Salmon, Terry Jones, 1990, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

Microglia, amyloid, and cognition in Alzheimer's disease: An [11C](R)PK11195-PET and [11C]PIB-PET study

Martin Rossor, Alexander Hammers, Paul Edison, 2008, Neurobiology of Disease.

Erratum: A proposal for a comprehensive grading of Parkinson's disease severity combining motor and non-motor assessments: Meeting an unmet need (PLoS ONE (2013) 8: 2 (e57221) DOI: 10.1371/journal.pone.0057221)

David J. Brooks, Angelo Antonini, Kallol Ray Chaudhuri, 2016 .

Imaging Activated Microglia in the Aging Human Brain

Federico E. Turkheimer, David J. Brooks, Richard B. Banati, 2001 .

Scan order effects in PET activation studies are caused by motion artefact

David J. Brooks, Matthew Brett, John F. Stein, 1999 .

Amyloid pathology and axonal injury after brain trauma

Paul Edison, Anil F. Ramlackhansingh, Federico E. Turkheimer, 2016, Neurology.